Rayscape vs Riverain Technologies (2026)
Two thoracic imaging companies with different theories about why findings get missed. Rayscape detects and localises across a large chest radiograph findings set, adds lung nodule work on computed tomography and compares against a patient's prior scans, with independent evaluation from a tuberculosis screening deployment. Riverain suppresses the vessels, on the argument that nodules are missed because vasculature hides them rather than because nobody looked, which changes what the radiologist sees rather than adding a list of what the model found. Those are complementary interventions and a lung programme could justify both. The question for either is the same and neither answers it publicly: how does the model perform on your scanners and your protocols, because thoracic algorithms are unusually sensitive to acquisition and degrade quietly when they move.
- Findings breadth on chest radiography is substantial and it adds longitudinal comparison across a patient's prior scans, so change is visible rather than inferred.
- Independent evaluation in a tuberculosis screening context tests the product where radiologist capacity is thinnest, which is a harder setting than a reading room study.
- On premise or cloud integration, with the appliance model suiting institutions that cannot send images out.
- Vessel suppression on chest computed tomography and radiography is a specific technical approach to a specific problem, making nodules visible that vasculature obscures rather than listing more findings.
- Long established thoracic focus means the products have been in clinical use through several generations of scanner and protocol change.
- For a lung nodule programme, a tool designed around the reason nodules are missed is different from a general findings detector.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Rayscape and Riverain Technologies are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Rayscape | Riverain Technologies |
|---|---|---|
| Primary category | Radiology & Imaging AI | Radiology & Imaging AI |
| Founded | 2019 | 2000 |
| Headquarters | Timisoara, Romania | Dayton, Ohio, United States |
| Website | rayscape.ai | riveraintech.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Rayscape its top capability grade on AI Centrality. Set against Riverain Technologies, Rayscape grades higher on several axes, including Model Supply Chain Disclosure, AI Safety and PHI Stewardship and HIPAA and BAA Posture. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Riverain Technologies its top capability grade on AI Centrality. Set against Rayscape, Riverain Technologies grades higher on FDA and Regulatory Status. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Rayscape or Riverain Technologies?
On the axes where the AI Health Index separates them, Rayscape grades higher on several axes, including Model Supply Chain Disclosure, AI Safety and PHI Stewardship and HIPAA and BAA Posture, and Riverain Technologies grades higher on FDA and Regulatory Status. Rayscape leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Rayscape and Riverain Technologies differ most?
The widest separation the AI Health Index records between Rayscape and Riverain Technologies is on Model Supply Chain Disclosure, where Rayscape grades B and Riverain Technologies grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Rayscape and Riverain Technologies grade the same?
The AI Health Index grades Rayscape and Riverain Technologies the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
The two take different technical routes to thoracic imaging and should not be compared on findings counts: suppression changes what the reader sees, while detection lists what the model found, and a department may reasonably use both. Neither publishes a security attestation or trust centre, and neither publishes pricing.
Ask both for performance on your own scanner mix and protocols, since thoracic algorithms are sensitive to acquisition parameters and a model validated elsewhere can degrade on your equipment without any visible signal in the output.